Amplia Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	27.85	10.86	3.39	9.26	14.61
Cash & Short-Term Investments	27.85	10.86	3.39	9.26	14.61
Cash Growth	156.41%	220.90%	-63.43%	-36.63%	690.33%
Other Receivables	4.78	3.77	3.18	1.15	1.84
Receivables	4.78	3.77	3.18	1.15	1.84
Prepaid Expenses	0.17	0.11	0.07	0.04	0.03
Other Current Assets	0.24	0.18	0.12	0.07	0.05
Total Current Assets	33.04	14.93	6.75	10.51	16.53
Property, Plant & Equipment	0.35	0.02	0.1	0.18	0.01
Other Intangible Assets	7.94	7.94	7.94	7.94	7.94
Other Long-Term Assets	0.11	0.05	0.05	0.05	-
Total Assets	41.44	22.94	14.85	18.68	24.48
Accounts Payable	1.49	1.56	1.6	0.35	0.37
Short-Term Debt	-	-	1.49	2.11	-
Current Portion of Leases	0.09	0.01	0.08	0.07	-
Other Current Liabilities	0.09	0.31	0.23	0.22	0.16
Total Current Liabilities	1.67	1.89	3.4	2.75	0.53
Long-Term Debt	-	-	-	-	2.1
Long-Term Leases	0.25	-	0.01	0.09	-
Other Long-Term Liabilities	0.05	0.02	0.01	0	0.01
Total Liabilities	1.97	1.91	3.43	2.85	2.64
Common Stock	193.43	167.39	151.53	151.53	151.51
Retained Earnings	-152.83	-145.54	-139.01	-134.72	-128.62
Comprehensive Income & Other	-1.13	-0.83	-1.1	-0.97	-1.04
Shareholders' Equity	39.47	21.02	11.42	15.84	21.85
Total Liabilities & Equity	41.44	22.94	14.85	18.68	24.48
Total Debt	0.34	0.01	1.59	2.28	2.1
Net Cash (Debt)	27.51	10.85	1.8	6.98	12.51
Net Cash Growth	153.59%	503.17%	-74.23%	-44.19%	576.70%
Net Cash Per Share	0.06	0.04	0.01	0.04	0.09
Filing Date Shares Outstanding	513.44	387.95	271.61	194.01	193.85
Total Common Shares Outstanding	513.44	387.95	194.01	194.01	193.85
Working Capital	31.37	13.04	3.35	7.76	16
Book Value Per Share	0.08	0.05	0.06	0.08	0.11
Tangible Book Value	31.53	13.09	3.48	7.9	13.91
Tangible Book Value Per Share	0.06	0.03	0.02	0.04	0.07
Machinery	-	-	-	-	0.02